Veraxa Biotech Holding AG (VRXA) Non-Current Debt (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Non-Current Debt for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Debt rose 51.32% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 51.32% YoY), and the FY2025 full-year result was $3.6 million, up 51.32% from the prior year.
• Non-Current Debt climbed to $3.6 million in Q4 2025 per VRXA's latest filing, from $2.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $3.6 million in Q4 2025 to a low of $2.4 million in Q4 2024.